Patents by Inventor Michael Patane

Michael Patane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20240417383
    Abstract: Provided herein are compounds and compositions useful in increasing PPAR? activity. The compounds and compositions provided herein are useful for the treatment of PPAR? related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Application
    Filed: January 25, 2024
    Publication date: December 19, 2024
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • COMPOUNDS AND COMPOSITIONS AS EIF4E INHIBITORS AND THE USES THEREOF
    Publication number: 20240246918
    Abstract: Described herein are compounds of Formula I, and their pharmaceutically acceptable salts, solvates, stereoisomers, or prodrugs, as well as their uses (e.g., as eIF4E inhibitors).
    Type: Application
    Filed: November 13, 2023
    Publication date: July 25, 2024
    Inventors: Rajeev BHIDE, Roheeth Kumar PAVANA, Stephen THOMSON, Ashis Kumar SAHA, Ramamurty V S CHANGALVALA, Stevan DJURIC, Ramesh Kumar SISTLA, Sundara Raghuram TANGIRALA, Laxmikant Shamlal DATRANGE, Samir Satish KHER, Saumya ROY, Suparna GUPTA, Michael PATANE, Ratnakumar SREEKANTHA, Simon HAYDER
  • PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20230373948
    Abstract: Provided herein are compounds and compositions useful in increasing PPAR? activity. The compounds and compositions provided herein are useful for the treatment of PPAR? related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Application
    Filed: February 13, 2023
    Publication date: November 23, 2023
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
    Patent number: 11578052
    Abstract: Provided herein are compounds and compositions useful in increasing PPAR? activity. The compounds and compositions provided herein are useful for the treatment of PPAR? related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: February 14, 2023
    Assignees: Mitobridge, Inc., The Salk Institute for Biological Studies
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • METHODS OF TREATING ACUTE KIDNEY INJURY
    Publication number: 20210283116
    Abstract: The present invention is directed to methods of treating a human patient with acute kidney injury.
    Type: Application
    Filed: October 5, 2017
    Publication date: September 16, 2021
    Applicants: Mitobridge, Inc., Mitobridge, Inc.
    Inventors: Bharat Lagu, Michael Patane, Effie Tozzo, Scott Trzaska
  • PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20210253549
    Abstract: Provided herein are compounds and compositions useful in increasing PPAR? activity. The compounds and compositions provided herein are useful for the treatment of PPAR? related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Application
    Filed: January 29, 2021
    Publication date: August 19, 2021
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
    Patent number: 10906885
    Abstract: Provided herein are compounds and compositions useful in increasing PPAR? activity. The compounds and compositions provided herein are useful for the treatment of PPAR? related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: February 2, 2021
    Assignees: Mitobridge, Inc., The Salk Institute for Biological Studies
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20200157074
    Abstract: Provided herein are compounds and compositions useful in increasing PPAR? activity. The compounds and compositions provided herein are useful for the treatment of PPAR? related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Application
    Filed: November 13, 2019
    Publication date: May 21, 2020
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
    Patent number: 10479775
    Abstract: Provided herein are compounds and compositions useful in increasing PPAR? activity. The compounds and compositions provided herein are useful for the treatment of PPAR? related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: November 19, 2019
    Assignees: Mitobridge, Inc., The Salk Institute for Biological Studies
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20190337920
    Abstract: Provided herein are compounds and compositions useful in increasing PPAR? activity. The compounds and compositions provided herein are useful for the treatment of PPAR? related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Application
    Filed: July 15, 2019
    Publication date: November 7, 2019
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
    Patent number: 10399958
    Abstract: Provided herein are compounds I, II or III and compositions useful in increasing PPAR8 activity. The compounds and compositions provided herein are useful for the treatment of PPAR8 related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: September 3, 2019
    Assignees: Mitobridge, Inc., The Salk Institute for Biological Studies
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20190084958
    Abstract: Provided herein are compounds I, II or III and compositions useful in increasing PPAR8 activity. The compounds and compositions provided herein are useful for the treatment of PPAR8 related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Application
    Filed: October 5, 2016
    Publication date: March 21, 2019
    Applicants: Mitobridge, Inc., The Salk Institute for Biological Studies
    Inventors: Michael Downes, Ronald M. Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
    Patent number: 10188627
    Abstract: Provided herein are compounds of formula (I) useful for the treatment of PPAR-delta related diseases (e.g. mitochondrial diseases, muscular diseases, vascular diseases, demyelinating diseases and metabolic diseases).
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: January 29, 2019
    Assignees: Mitobridge, Inc., Salk Institute for Biological Studies
    Inventors: Michael Downes, Ronald Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20170305894
    Abstract: Provided herein are compounds of Formula (I) and compositions useful in increasing PPARS activity. The compounds and compositions provided herein are useful for the treatment of PPARS related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
    Type: Application
    Filed: October 7, 2015
    Publication date: October 26, 2017
    Inventors: Thomas Baiga, Michael Downes, Ronald Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20170304255
    Abstract: Provided herein are compounds of formula (I) useful for the treatment of PPAR-delta related diseases (e.g. mitochondrial diseases, muscular diseases, vascular diseases, demyelinating diseases and metabolic diseases).
    Type: Application
    Filed: October 7, 2015
    Publication date: October 26, 2017
    Inventors: Thomas Baiga, Michael Downes, Ronald Evans, Arthur Kluge, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi, Michael Patane, Susanta Samajdar, Ramesh Senaiar, Taisuke Takahashi
  • Copolymers of starch and cellulose
    Patent number: 9745699
    Abstract: Copolymers comprising cellulose and starch connected by at least one cross-linker, methods of producing the copolymers, and formed articles comprising the copolymers are described herein. The copolymers may be biodegradable and may have improved physical properties when compared to the homopolymers and other biodegradable polymers. In some embodiments, the copolymer may be more flexible than unmodified cellulose may have better structural integrity than unmodified starch.
    Type: Grant
    Filed: November 6, 2012
    Date of Patent: August 29, 2017
    Assignee: Empire Technology Development LLC
    Inventor: Michael Patane
  • Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E
    Patent number: 9409901
    Abstract: Disclosed herein are compounds, compositions, formulations, kits and methods of treatment useful for treating or preventing one or more hyperproliferative disorders, e.g., cancer or a neurological disease or disorder.
    Type: Grant
    Filed: October 22, 2013
    Date of Patent: August 9, 2016
    Assignee: Bantam Pharmaceutical, LLC
    Inventor: Michael Patane
  • COPOLYMERS OF STARCH AND CELLULOSE
    Publication number: 20150299957
    Abstract: Copolymers comprising cellulose and starch connected by at least one cross-linker, methods of producing the copolymers, and formed articles comprising the copolymers are described herein. The copolymers may be biodegradable and may have improved physical properties when compared to the homopolymers and other biodegradable polymers. In some embodiments, the copolymer may be more flexible than unmodified cellulose may have better structural integrity than unmodified starch.
    Type: Application
    Filed: November 6, 2012
    Publication date: October 22, 2015
    Inventor: Michael PATANE
  • Compositions And Methods For Treating Or Preventing Diseases Or Disorders Associated With Misregulated EIF4E
    Publication number: 20150274717
    Abstract: Disclosed herein are compounds, compositions, formulations, kits and methods of treatment useful for treating or preventing one or more hyperproliferative disorders, e.g., cancer or a neurological disease or disorder.
    Type: Application
    Filed: October 22, 2013
    Publication date: October 1, 2015
    Inventor: Michael Patane
  • Jug
    Patent number: D1126769
    Type: Grant
    Filed: January 15, 2025
    Date of Patent: May 19, 2026
    Assignee: MPL Brands NV, Inc.
    Inventor: Michael Patane